Profil
Le Dr Adam L. Tomasi est président et directeur de l'exploitation chez Allakos, Inc. Il est membre du conseil d'administration d'Attune Pharmaceuticals, Inc. Auparavant, le Dr. Tomasi a été employé en tant que directeur scientifique par ZS Pharma, Inc, directeur par Alta Partners Management Corp, chimiste médicinal par Cytokinetics, Inc, et chimiste médicinal par Gilead Sciences, Inc. Il a obtenu son diplôme de premier cycle à l'université de Californie, Berkeley, un MBA à la Sloan School of Management du MIT et un doctorat à l'université de Californie, Irvine.
Postes actifs de Adam Tomasi
| Sociétés | Poste | Début |
|---|---|---|
Attune Pharmaceuticals, Inc.
Attune Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel orally-administered small-molecule therapeutics for the treatment of rare diseases | Directeur/Membre du Conseil | - |
LifeSci Acquisition III Corp.
LifeSci Acquisition III Corp. Financial ConglomeratesFinance Operates as a blank check company | Directeur/Membre du Conseil | - |
Anciens postes connus de Adam Tomasi
| Sociétés | Poste | Fin |
|---|---|---|
| ALLAKOS INC. | Directeur Financier/CFO | 19/04/2021 |
| ZS PHARMA INC | Directeur Technique/Scientifique/R&D | 01/03/2017 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
| CYTOKINETICS, INCORPORATED | Corporate Officer/Principal | - |
Alta Partners Management Co. LP
Alta Partners Management Co. LP Investment ManagersFinance Alta Partners invests in companies located in the United States. The firm focuses on life sciences and healthcare technology services sectors. It participates in seed, early and later stage capital transactions. It acts as the lead investor and takes a seat on board of directors. | Private Equity Investor | - |
Formation de Adam Tomasi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Alta Partners Management Co. LP
Alta Partners Management Co. LP Investment ManagersFinance Alta Partners invests in companies located in the United States. The firm focuses on life sciences and healthcare technology services sectors. It participates in seed, early and later stage capital transactions. It acts as the lead investor and takes a seat on board of directors. | Finance |
Cytokinetics, Inc.
Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
ZS Pharma, Inc.
ZS Pharma, Inc. BiotechnologyHealth Technology Develops develop new treatments of kidney and liver diseases | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Irvine
University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allakos, Inc.
Allakos, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops innovative therapeutics which target immunomodulatory receptors for the treatment of allergic, inflammatory and proliferative diseases | Health Technology |
MIT Sloan School of Management
MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Attune Pharmaceuticals, Inc.
Attune Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel orally-administered small-molecule therapeutics for the treatment of rare diseases | Commercial Services |
LifeSci Acquisition III Corp.
LifeSci Acquisition III Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
















